PTC Therapeutics Inc - ESG Rating & Company Profile powered by AI
The ESG rating for PTC Therapeutics Inc represents the company's transparency towards the UN Sustainable Development Goals. This ESG score includes 17 United Nations SDGs including: 'Quality Education', 'Responsible Production & Consumption' and 'Partnerships for the Goals'. The webpage includes a questions and answers table about PTC Therapeutics Inc.
PTC Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.4; made up of an environmental score of 0.0, social score of 4.6 and governance score of 2.7.
2.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1499 | Verici Dx Plc | 2.5 | Medium |
| 1499 | Verve Therapeutics Inc | 2.5 | Medium |
| 1512 | PTC Therapeutics Inc | 2.4 | Medium |
| 1512 | CEL-SCI Corp | 2.4 | Medium |
| 1512 | Allena Pharmaceuticals Inc | 2.4 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does PTC Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes PTC Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes PTC Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes PTC Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes PTC Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes PTC Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes PTC Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes PTC Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid PTC Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes PTC Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas PTC Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes PTC Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes PTC Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs PTC Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes PTC Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes PTC Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes PTC Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for PTC Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean; and markets Evrysdi for the treatment of spinal muscular atrophy in adults and children two months and older in Brazil. The company's splicing platform includes PTC518, which is being developed for the treatment of Huntington's disease. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation to advance drug discovery and development research in regenerative medicine; and Akcea Therapeutics, Inc. to commercialize Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.